These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

720 related items for PubMed ID: 19625168

  • 1. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS, Raghunathan R, Ekambaram R, Raghunathan M.
    Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J, Yue J, Wu J, Luo R, Hu Z, Li J, Bai Y, Tang Z, Xian Q, Zhang X, Wang H.
    Pharmacology; 2010 Nov; 85(6):365-71. PubMed ID: 20530976
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activities of the new quinolone nemonoxacin (TG-873870), gemifloxacin and other quinolones against clinical isolates of Mycobacterium tuberculosis.
    Tan CK, Lai CC, Liao CH, Chou CH, Hsu HL, Huang YT, Hsueh PR.
    J Antimicrob Chemother; 2009 Aug; 64(2):428-9. PubMed ID: 19454523
    [No Abstract] [Full Text] [Related]

  • 6. Study of the in vitro susceptibility of M. tuberculosis to ofloxacin in Spain. Spanish Study Group of M. tuberculosis resistance.
    Casal M, Ruiz P, Herreras A.
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):588-91. PubMed ID: 10864193
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H, Haraguchi Y, Itotani M, Kuroda H, Hashizume H, Tomishige T, Kawasaki M, Matsumoto M, Komatsu M, Tsubouchi H.
    J Med Chem; 2006 Dec 28; 49(26):7854-60. PubMed ID: 17181168
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
    Dutta NK, Mazumdar K, Dastidar SG, Park JH.
    Int J Antimicrob Agents; 2007 Oct 28; 30(4):336-40. PubMed ID: 17644321
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolates.
    Pucci MJ, Ackerman M, Thanassi JA, Shoen CM, Cynamon MH.
    Antimicrob Agents Chemother; 2010 Aug 28; 54(8):3478-80. PubMed ID: 20516287
    [Abstract] [Full Text] [Related]

  • 14. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.
    Protopopova M, Hanrahan C, Nikonenko B, Samala R, Chen P, Gearhart J, Einck L, Nacy CA.
    J Antimicrob Chemother; 2005 Nov 28; 56(5):968-74. PubMed ID: 16172107
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model.
    Cremades R, Rodríguez JC, García-Pachón E, Galiana A, Ruiz-García M, López P, Royo G.
    J Antimicrob Chemother; 2011 Oct 28; 66(10):2281-3. PubMed ID: 21733966
    [Abstract] [Full Text] [Related]

  • 17. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis.
    De Logu A, Palchykovska LH, Kostina VH, Sanna A, Meleddu R, Chisu L, Alexeeva IV, Shved AD.
    Int J Antimicrob Agents; 2009 Mar 28; 33(3):223-9. PubMed ID: 19070992
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
    Molina-Torres CA, Ocampo-Candiani J, Rendón A, Pucci MJ, Vera-Cabrera L.
    Antimicrob Agents Chemother; 2010 May 28; 54(5):2188-90. PubMed ID: 20231398
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility testing of Mycobacterium tuberculosis complex strains isolated from seals to antituberculosis drugs.
    Bernardelli A, Morcillo N, Loureiro J, Quse V, Davenport S.
    Biomedica; 2004 Jun 28; 24 Supp 1():85-91. PubMed ID: 15495576
    [Abstract] [Full Text] [Related]

  • 20. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Tomioka H, Sato K, Kajitani H, Akaki T, Shishido S.
    Antimicrob Agents Chemother; 2000 Feb 28; 44(2):283-6. PubMed ID: 10639351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.